Literature DB >> 10997464

Angioplasty and stent placement in chronic occlusion of the superficial femoral artery: technique and results.

R M Conroy1, I L Gordon, J M Tobis, T Hiro, S Kasaoka, E A Stemmer, S E Wilson.   

Abstract

PURPOSE: To improve the patency rate for angioplasty in chronic occlusion of the superficial femoral artery by deploying stents after angioplasty.
MATERIALS AND METHODS: Angioplasty and stent placement were performed in 61 arteries in 48 male patients. The mean occlusion length was 13.5 cm and the mean stent length was 30 cm. Patency rates were analyzed at 6 months and at 1, 2, 3, and 4 years. The predictors of restenosis were analyzed by univariate and multiple logistic regression.
RESULTS: Patency rates were 87% at 6 months, consisting of 74% primary, 6% primary assisted, and 7% secondary; 79% at 1 year, consisting of 47% primary, 19% primary assisted, and 13% secondary; 72% at 2 years, consisting of 36% primary, 26% primary assisted, and 10% secondary; 70% at 3 years, consisting of 26% primary, 22% primary assisted, and 22% secondary; and 63% at 4 years, consisting of 25% primary, 0% primary assisted, and 38% secondary. There was a 15% morbidity rate and one mortality as a result of retroperitoneal bleeding. Better patency rates were noted at all time intervals in diabetic limbs, 7-mm-diameter versus 10-mm-diameter stents, shorter obstructions and shorter stents, nonsmokers, in limbs in which urokinase was not necessary after stent deployment, and in limbs with an International Society of Cardiovascular Surgery (ISCVS) classification under 3. Patency rates were not affected by age, race, number of trifurcation vessels patent, experience in performing the procedures, and procedures requiring less time. By multivariate logistic analysis, the independent predictors of patency at 6 months were postprocedure ankle/brachial index (ABI) and shorter stent length; at 1 year, preprocedure ABI, shorter stent length, and the presence of diabetes; at 2 years, preprocedure ABI and the presence of diabetes; and at 3 years, the preprocedure ABI.
CONCLUSIONS: The techniques used to reestablish antegrade flow in these superficial femoral arteries yielded a high success rate. In addition, the use of angioplasty with stents may improve patency rates over angioplasty without stents.

Entities:  

Mesh:

Year:  2000        PMID: 10997464     DOI: 10.1016/s1051-0443(07)61331-1

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  7 in total

1.  Percutaneous treatment of complete chronic occlusions of the superficial femoral artery.

Authors:  D Laganà; G Carrafiello; M Dizonno; M Barresi; R Caronno; P Castelli; C Fugazzola
Journal:  Radiol Med       Date:  2008-05-20       Impact factor: 3.469

2.  "Full metal jacket" with direct stenting of complete chronic occlusions of the superficial femoral artery.

Authors:  D Laganà; G Carrafiello; M Barresi; D Lumia; M Dizonno; F A Vizzari; F Fontana; M Mangini; P Castelli; C Fugazzola
Journal:  Radiol Med       Date:  2011-01-12       Impact factor: 3.469

3.  Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: midterm analysis.

Authors:  A J Misselt; M D Zielinski; O I Garcia Medina; G Oderich; H Bjarnason; M A McKusick; Sanjay Misra
Journal:  Angiology       Date:  2011-08-25       Impact factor: 3.619

Review 4.  Endovascular stents for intermittent claudication.

Authors:  Paul Bachoo; P A Thorpe; Heather Maxwell; Karen Welch
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  The primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patients.

Authors:  Il Soo Chang; Hyun Keun Chee; Sang Woo Park; Ik Jin Yun; Jae Joon Hwang; Song Am Lee; Jun Seok Kim; Seong-Hwan Chang; Hong Geun Jung
Journal:  Korean J Radiol       Date:  2011-03-03       Impact factor: 3.500

6.  Strategies for successful percutaneous revascularization of chronic total occlusion of the femoropopliteal arteries when the antegrade passage of a guide wire fails.

Authors:  Hui Jin Lee; Sang Woo Park; Il Soo Chang; Hae Jeong Jeon; Jeong Hee Park
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

7.  A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine.

Authors:  Ichiro Ikushima; Kazuchika Yonenaga; Hironao Iwakiri; Hideki Nagoshi; Haruhito Kumagai; Yasuyuki Yamashita
Journal:  Med Devices (Auckl)       Date:  2011-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.